Impact of -Derived Outer Membrane Vesicles on Inflammation, Immune Responses, and Tumor Cell Migration in Breast Cancer Through the Snail/Β-Catenin Pathway

Overview

Journal Rep Biochem Mol Biol

Specialty Biochemistry

Date 2025 Feb 25

PMID 39995644

Authors

Seyedeh Shadi Vaziri

Elahe Tajbakhsh

Faham Khamesipour

Hassan Momtaz

Zohre Mazaheri

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer remains a significant global health concern, with challenges in treating advanced stages necessitating the exploration of novel therapeutic approaches. Bacterial outer membrane vesicles (OMVs) have shown promise in cancer immunotherapy by targeting cancer cells and modulating immune responses. This study investigated the effects of Helicobacter pylori-derived OMVs on the activation of the Snail/β-Catenin gene cascade in regulating inflammation and cell migration in a mouse model of breast cancer.

Methods: The OMVs were extracted from the culture of strain 26695 (ATCC 700392) using ultracentrifugation. In the mouse model, the vesicles were injected intraperitoneally into Balb/c mice with breast tumors. Tumor growth was assessed through histological examination of tumor samples. IgA and IgG antibodies were measured using ELISA. The expression of E-cadherin and vimentin proteins was evaluated by immunohistochemistry, and real-time PCR was used for vimentin, Snail, α-SMA, and β-catenin in serum samples from the different groups.

Results: The OMV treatment led to a significant increase in the expression of α-SMA, β-catenin, Snail, and vimentin genes, indicating a potential induction of epithelial-mesenchymal transition and enhanced cancer cell growth. Additionally, a decrease in vimentin expression and an increase in E-cadherin expression were observed, suggesting inhibition of cell migration. The study also revealed alterations in systemic IgA and IgG antibody levels, indicating potential immunomodulatory effects of OMVs.

Conclusions: These findings highlight the therapeutic potential of OMVs derived from in breast cancer treatment by targeting gene cascades involved in cancer progression and modulating immune responses.

References

Aromaa A, Kosunen T, Knekt P, Maatela J, Teppo L, Heinonen O . Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol. 1996; 144(2):142-9. DOI: 10.1093/oxfordjournals.aje.a008901. View

Rezaei Adriani R, Mousavi Gargari S, Bakherad H, Amani J . Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model. Sci Rep. 2023; 13(1):16403. PMC: 10541432. DOI: 10.1038/s41598-023-43762-y. View

Yastrebova M, Khamidullina A, Tatarskiy V, Scherbakov A . Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy. Acta Naturae. 2021; 13(1):76-90. PMC: 8084295. DOI: 10.32607/actanaturae.11062. View

Furuyama N, Sircili M . Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application. Biomed Res Int. 2021; 2021:1490732. PMC: 8016564. DOI: 10.1155/2021/1490732. View

Espinosa-Ramos D, Caballero-Hernandez D, Gomez-Flores R, Trejo-Chavez A, Perez-Limon L, De la Garza-Ramos M . Immunization with a Synthetic Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection. Can J Infect Dis Med Microbiol. 2019; 2019:8595487. PMC: 6466936. DOI: 10.1155/2019/8595487. View

Hassan Al-Saeedi R, Khalaj-Kondori M, Feizi M, Hajavi J . DOX-PLGA Nanoparticles Effectively Suppressed the Expression of Pro-Inflammatory Cytokines TNF-a, IL-6, iNOS, and IL-1β in MCF-7 Breast Cancer Cell Line. Rep Biochem Mol Biol. 2024; 12(4):530-539. PMC: 11288233. DOI: 10.61186/rbmb.12.4.530. View

Mutebi M, Anderson B, Duggan C, Adebamowo C, Agarwal G, Ali Z . Breast cancer treatment: A phased approach to implementation. Cancer. 2020; 126 Suppl 10:2365-2378. DOI: 10.1002/cncr.32910. View

Usman S, Waseem N, Nguyen T, Mohsin S, Jamal A, Teh M . Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel). 2021; 13(19). PMC: 8507690. DOI: 10.3390/cancers13194985. View

Makki J . Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2016; 8:23-31. PMC: 4689326. DOI: 10.4137/CPath.S31563. View

10.

Liu J, Martin H, Shamay M, Woodard C, Tang Q, Hayward S . Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation. J Virol. 2007; 81(9):4722-31. PMC: 1900136. DOI: 10.1128/JVI.02548-06. View

11.

Ngo H, Lee H, Piao J, Zhong X, Lee H, Han H . Helicobacter pylori induces Snail expression through ROS-mediated activation of Erk and inactivation of GSK-3β in human gastric cancer cells. Mol Carcinog. 2016; 55(12):2236-2246. DOI: 10.1002/mc.22464. View

12.

Shi L, Shangguan J, Lu Y, Rong J, Yang Q, Yang Y . ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression. J Transl Med. 2024; 22(1):148. PMC: 10863176. DOI: 10.1186/s12967-024-04913-5. View

13.

Li Y, Wu J, Qiu X, Dong S, He J, Liu J . Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy. Bioact Mater. 2022; 20:548-560. PMC: 9253654. DOI: 10.1016/j.bioactmat.2022.05.037. View

14.

Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo A, Magnani M . Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene. 2002; 21(53):8192-5. DOI: 10.1038/sj.onc.1205921. View

15.

Sabzi S, Habibi M, Badmasti F, Shahbazi S, Asadi Karam M, Farokhi M . Polydopamine-based nano adjuvant as a promising vaccine carrier induces significant immune responses against Acinetobacter baumannii-associated pneumonia. Int J Pharm. 2024; 654:123961. DOI: 10.1016/j.ijpharm.2024.123961. View

16.

Humar B, Blair V, Charlton A, More H, Martin I, Guilford P . E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res. 2009; 69(5):2050-6. DOI: 10.1158/0008-5472.CAN-08-2457. View

17.

Qaed Ahmed A, Besio R, Xiao L, Forlino A . Outer Membrane Vesicles (OMVs) as Biomedical Tools and Their Relevance as Immune-Modulating Agents against Infections: Current Status and Future Prospects. Int J Mol Sci. 2023; 24(10). PMC: 10218342. DOI: 10.3390/ijms24108542. View

18.

Mobarez A, Soleimani N, Esmaeili S, Farhangi B . Nanoparticle-based immunotherapy of breast cancer using recombinant Helicobacter pylori proteins. Eur J Pharm Biopharm. 2020; 155:69-76. DOI: 10.1016/j.ejpb.2020.08.013. View

19.

Ahmadzadeh A, Khodayar M, Salehcheh M, Khorasgani Z, Matin M . Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients. Rep Biochem Mol Biol. 2024; 12(2):277-283. PMC: 10838599. DOI: 10.61186/rbmb.12.2.277. View

20.

Zucchini-Pascal N, Peyre L, Rahmani R . Crosstalk between beta-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1/2 pathway. Int J Mol Sci. 2013; 14(10):20768-92. PMC: 3821642. DOI: 10.3390/ijms141020768. View